SUSTAINED-RELEASE FORMULATION COMPRISING METFORMIN OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND METHOD FOR PREPARING SAME
WO2026127322A1 · Application publication visible
Patent Applicant View
DAEWOONG THERAPEUTICS INC [KR]
Explore source-linked longevity patent families and topic connections associated with the applicant name DAEWOONG THERAPEUTICS INC [KR].
Applicant activity
1 source-linked patent families
This independent page groups EPO bibliographic records in which this name appears as an applicant or assignee. It is not a corporate profile, ownership opinion, portfolio valuation or ranking.